Autoimmune Hemolytic Anemia with Myelodysplastic Syndrome

Autor:	Carla Chalouhy, Seth J Page, Elie Chalhoub, Rami Jambeih
Rok vydání:	2013
Předmět:	Radiation therapy Chemotherapy business.industry hemic and lymphatic diseases Myelodysplastic syndromes medicine.medical_treatment Immunology Medicine Chromosome Autoimmune hemolytic anemia business medicine.disease Trisomy
Zdroj:	Kansas Journal of Medicine. 6:94-97
ISSN:	1948-2035
DOI:	10.17161/kjm.v6i3.11448
Popis:	Risk factors for development of MDS include prior chemotherapy, radiation therapy, smoking, and exposure to benzene. The most common cytogenetic alteration in MDS is a deletion of the short arm of chromosome 5. We report a patient with an isolated trisomy 21, which constitutes about 1.1-2.2 % of the total cytogenetic alterations in MDS.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c2a810c33f968993f4764c7057b5ac6a https://doi.org/10.17161/kjm.v6i3.11448 Zobrazit plný text záznamu